ABBOTT LABORATORIES (ABT) Stock Price & Overview
NYSE:ABT • US0028241000
Current stock price
The current stock price of ABT is 109.4 USD. Today ABT is down by -1.18%. In the past month the price decreased by -1.38%. In the past year, price decreased by -12.37%.
ABT Key Statistics
- Market Cap
- 190.102B
- P/E
- 21.24
- Fwd P/E
- 19.05
- EPS (TTM)
- 5.15
- Dividend Yield
- 2.33%
ABT Stock Performance
ABT Stock Chart
ABT Technical Analysis
ChartMill assigns a technical rating of 0 / 10 to ABT. When comparing the yearly performance of all stocks, ABT is a bad performer in the overall market: 79.02% of all stocks are doing better.
ABT Fundamental Analysis
ChartMill assigns a fundamental rating of 7 / 10 to ABT. ABT scores excellent points on both the profitability and health parts. This is a solid base for a good stock.
ABT Earnings
On January 22, 2026 ABT reported an EPS of 1.5 and a revenue of 11.46B. The company missed EPS expectations (-0.75% surprise) and missed revenue expectations (-3.88% surprise).
ABT Forecast & Estimates
35 analysts have analysed ABT and the average price target is 136.02 USD. This implies a price increase of 24.34% is expected in the next year compared to the current price of 109.4.
For the next year, analysts expect an EPS growth of 11.53% and a revenue growth 7% for ABT
ABT Groups
Sector & Classification
ABT Financial Highlights
Over the last trailing twelve months ABT reported a non-GAAP Earnings per Share(EPS) of 5.15. The EPS increased by 10.28% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 14.72% | ||
| ROA | 7.52% | ||
| ROE | 12.51% | ||
| Debt/Equity | 0.19 |
ABT Ownership
ABT Latest News, Press Relases and Analysis
ABT Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ISRG | INTUITIVE SURGICAL INC | 46.82 | 171.443B | ||
| SYK | STRYKER CORP | 23.03 | 133.601B | ||
| BSX | BOSTON SCIENTIFIC CORP | 20.22 | 105.653B | ||
| EW | EDWARDS LIFESCIENCES CORP | 27.66 | 48.944B | ||
| IDXX | IDEXX LABORATORIES INC | 39.28 | 46.735B | ||
| BDX | BECTON DICKINSON AND CO | 11.54 | 46.025B | ||
| RMD | RESMED INC | 18.82 | 34.016B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 13.84 | 32.969B | ||
| DXCM | DEXCOM INC | 26.6 | 25.909B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 10.68 | 18.102B | ||
| HOLX | HOLOGIC INC | 15.31 | 16.754B | ||
| PODD | INSULET CORP | 35.62 | 16.227B |
Related stock screener links
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the New York Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About ABT
Company Profile
Abbott Laboratories engages in the discovery, development, manufacture, and sale of healthcare products. The company is headquartered in Abbott Park, Illinois and currently employs 115,000 full-time employees. The Company’s principal business is the discovery, development, manufacture, and sale of a broad and diversified line of healthcare products. Its segments include Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. Established Pharmaceutical Products segment is engaged in the international sales of a broad line of branded generic pharmaceutical products. Diagnostic Products segment is involved in the worldwide sales of diagnostic systems and tests for blood banks, hospitals, commercial laboratories and alternate-care testing sites. Nutritional Products segment is engaged in the worldwide sales of a broad line of adult and pediatric nutritional products. Medical Devices segment is involved in the worldwide sales of rhythm management, electrophysiology, heart failure, vascular, structural heart, neuromodulation and diabetes care products. The company serves people in more than 160 countries.
Company Info
IPO: 1937-03-01
ABBOTT LABORATORIES
100 Abbott Park Road, Abbot Park
ABBOTT PARK ILLINOIS 60064 US
CEO: Robert B. Ford
Employees: 114000
Phone: 12246676100
ABBOTT LABORATORIES / ABT FAQ
What does ABT do?
Abbott Laboratories engages in the discovery, development, manufacture, and sale of healthcare products. The company is headquartered in Abbott Park, Illinois and currently employs 115,000 full-time employees. The Company’s principal business is the discovery, development, manufacture, and sale of a broad and diversified line of healthcare products. Its segments include Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. Established Pharmaceutical Products segment is engaged in the international sales of a broad line of branded generic pharmaceutical products. Diagnostic Products segment is involved in the worldwide sales of diagnostic systems and tests for blood banks, hospitals, commercial laboratories and alternate-care testing sites. Nutritional Products segment is engaged in the worldwide sales of a broad line of adult and pediatric nutritional products. Medical Devices segment is involved in the worldwide sales of rhythm management, electrophysiology, heart failure, vascular, structural heart, neuromodulation and diabetes care products. The company serves people in more than 160 countries.
What is the stock price of ABBOTT LABORATORIES today?
The current stock price of ABT is 109.4 USD. The price decreased by -1.18% in the last trading session.
Does ABT stock pay dividends?
ABBOTT LABORATORIES (ABT) has a dividend yield of 2.33%. The yearly dividend amount is currently 2.37.
What is the ChartMill rating of ABBOTT LABORATORIES stock?
ABT has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 7 out of 10.
Where is ABBOTT LABORATORIES (ABT) stock traded?
ABT stock is listed on the New York Stock Exchange exchange.
How is the market expecting ABT stock to perform?
35 analysts have analysed ABT and the average price target is 136.02 USD. This implies a price increase of 24.34% is expected in the next year compared to the current price of 109.4.
Should I buy ABT stock?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on ABT.